ARCHIVES

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Citizens Committee Notes Broad Support For NCI Funds

August 24, 1979

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007

Hammer Says He’ll Demand Construction Funds If Data Supports The Need

August 12, 1983

NCI Advisory Group, Other Cancer Meetings

February 24, 1984

Construction Funds Far Short Of NCA request; Terry Sees No Improvement

October 3, 1980